![]() |
½ÃÀ庸°í¼
»óÇ°ÄÚµå
1527299
¼¼°èÀÇ ¿©µå¸§ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð Á¶»ç : Ä¡·á Ŭ·¡½ºº°, Á¦Çüº°, À¯Çüº°, ¿©µå¸§ À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)Global Acne Medication Market Size Study, by Therapeutic Class, by Formulation, by Type, by Acne Type, by Distribution Channel and Regional Forecasts 2022-2032 |
¼¼°èÀÇ ¿©µå¸§ Ä¡·áÁ¦ ½ÃÀåÀº 2023³â¿¡´Â ¾à 134¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2024-2032³â¿¡´Â 5.1% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¿©µå¸§ Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀåÀº ¿©µå¸§ À¯º´·üÀÇ ±Þ°ÝÇÑ Áõ°¡¿Í È¿°úÀûÀÎ Ä¡·á¹ý °³¹ßÀ» À§ÇÑ ¿¬±¸ Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ±¹¸³ ÀÇÇÐ µµ¼°üÀÇ 2023³â ³í¹®¿¡ µû¸£¸é ¿©µå¸§Àº ¸Å¿ì ÈçÇÑ ¸¸¼º ¿°Áõ¼º ÇǺΠÁúȯÀ¸·Î ÁַΠû¼Ò³â°ú ÀþÀº ¼ºÀο¡°Ô ¹ß»ýÇϸç û¼Ò³âÀÇ Àü ¼¼°è À¯º´·üÀº ¾à 80%¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ¶ÇÇÑ °Ç°¿¡ ÇØ·Î¿î »ýÈ°½À°ü, ºÒ±ÔÄ¢ÇÑ ½Ä½À°ü, ¿îµ¿ ºÎÁ·, ½ºÆ®·¹½º µîÀÌ ¿©µå¸§ ¹ß»ý·üÀ» Áõ°¡½ÃÅ°´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÕ´Ï´Ù. ¿©µå¸§Àº Àü ¼¼°è¿¡¼ ¼ö¹é¸¸ ¸íÀÌ ¾Î°í ÀÖ´Â ÈçÇÑ ÇǺΠÁúȯÀ¸·Î ÇÇÁö °ú´Ù ºÐºñ, ¸ð°ø ¸·Èû, ¼¼±Õ Áõ½Ä, ¿°Áõ µîÀÌ ÁÖ¿ä ¿øÀÎÀÔ´Ï´Ù. Ä¡·á¹ýÀº ´Ù¾çÇϸç, ¿©µå¸§ÀÇ Á¤µµ¿Í À¯Çü¿¡ µû¶ó ¿©·¯ °¡Áö ¾à¹°À» Á¶ÇÕÇÏ¿© Ä¡·áÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. Æ®·¹Æ¼³ëÀÎÀ̳ª ¾Æ´ÙÆÈ·»°ú °°Àº ·¹Æ¼³ëÀ̵å´Â ¸ð°ø ¸·ÈûÀ» Á¦°ÅÇÏ°í ÇǺΠ¼¼Æ÷ÀÇ ÅÏ¿À¹ö¸¦ ÃËÁøÇÏ´Â °·ÂÇÑ ¿Ü¿ëÁ¦ÀÔ´Ï´Ù. Ç×»ýÁ¦´Â ³»º¹ ¶Ç´Â ¿Ü¿ëÁ¦·Î ¿©µå¸§À» À¯¹ßÇÏ´Â ¹ÚÅ׸®¾Æ¿Í ½Î¿ì°í ¿°ÁõÀ» ¾ïÁ¦ÇÏÁö¸¸, Ç×»ýÁ¦ ³»¼º¿¡ ´ëÇÑ ¿ì·Á´Â ¿©ÀüÇÕ´Ï´Ù. »ì¸®½Ç»ê°ú °ú»êȺ¥Á¶ÀÏÀº ÀϹÝÀûÀ¸·Î ó¹æµÇ´Â ¿©µå¸§ Ä¡·áÁ¦ÀÔ´Ï´Ù.
¼¼°è ¿©µå¸§ Ä¡·áÁ¦ ½ÃÀåÀº ¸î °¡Áö ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÎÇØ °·ÂÇÑ ¼ºÀåÀ» º¸ÀÌ°í ÀÖ½À´Ï´Ù. ¿©µå¸§ À¯º´·ü Áõ°¡, °Ç°¿¡ ÇØ·Î¿î »ýÈ°½À°ü, Àü ¼¼°è û¼Ò³â Áõ°¡´Â ½ÃÀå È®´ë¿¡ Å©°Ô ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù. ÇǺΠ°ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÇǺΠ°ü¸®¿¡ ´ëÇÑ Á߿伺ÀÌ ³ô¾ÆÁö¸é¼ ¿©µå¸§ Ä¡·á¸¦ ã´Â »ç¶÷µéÀÌ ´Ã¾î³ª¸é¼ ¿©µå¸§ Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. »çÃá±â È£¸£¸ó º¯È¸¦ Ư¡À¸·Î Çϴ û¼Ò³â Áõ°¡´Â ¿©µå¸§ÀÇ À¯º´·ü°ú Á÷Á¢ÀûÀÎ »ó°ü°ü°è°¡ ÀÖÀ¸¸ç, ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ°í ÀÖ½À´Ï´Ù. ºÒ±ÔÄ¢ÇÑ ½Ä½À°ü, ¿îµ¿ ºÎÁ·, ¼ö¸é ºÎÁ·, ÷´Ü ½ºÆ®·¹½º µî °Ç°¿¡ ÇØ·Î¿î »ýÈ°½À°ü ¼±ÅÃÀº ¿©µå¸§ÀÇ ¹ß»ý°ú ¾ÇÈ¿¡ ±â¿©ÇÕ´Ï´Ù. °¡°ø½ÄÇ°, ´ÞÄÞÇÑ °£½Ä, °íÇ÷´ç Áö¼ö ½ÄÇ°ÀÌ ¸¹Àº ½Ä´ÜÀº Àν¶¸° ¼öÄ¡¸¦ ±Þ»ó½Â½ÃÅ°°í ü³» ¿°ÁõÀ» ÃËÁøÇÒ ¼ö ÀÖÀ¸¹Ç·Î ¿©µå¸§ ¿©µå¸§ÀÇ À§Çè Áõ°¡¿Í °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ¿©µå¸§ Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÅ°´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÏ°í ÀÖ½À´Ï´Ù. ±×·¯³ª Ç×»ýÁ¦ ³»¼º¿¡ ´ëÇÑ ¿ì·Á¿Í °í°¡ÀÇ Ä¡·áºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¼¼°èÀÇ ¿©µå¸§ Ä¡·áÁ¦ ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â 2023³â ¿©µå¸§ Ä¡·áÁ¦ ½ÃÀåÀÇ ÁÖ¿ä Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ¿¹Ãø ±â°£ Áß ±× ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ¹ß´ÞµÈ ÀÇ·á ÀÎÇÁ¶ó, ÁÖ¿ä ´ë±â¾÷ÀÇ Á¸Àç°¨, ÇǺΠ°ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁø µ¥ ±âÀÎÇÕ´Ï´Ù. ±×·¯³ª ¾Æ½Ã¾ÆÅÂÆò¾çÀº 10´ë Àα¸ÀÇ ±ÞÁõ°ú °¡Ã³ºÐ ¼Òµæ Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Global Acne Medication Market is valued approximately at USD 13.4 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2024-2032. The growth of the acne medication market is driven by a surge in the prevalence of acne and increased research for developing effective treatments. According to a 2023 article by the National Library of Medicine, acne is a very common chronic inflammatory skin disease that predominantly affects adolescents and young adults, with a global prevalence of about 80% among adolescents. Additionally, unhealthy lifestyles, poor diets, lack of exercise, and stress have resulted in a rise in the incidence of acne. Acne is a common skin condition affecting millions globally, primarily caused by excess oil production, clogged pores, bacteria proliferation, and inflammation. Treatment approaches vary, often involving a combination of medications tailored to the severity and type of acne. Retinoids, such as tretinoin and adapalene, are potent topical treatments that unclog pores and promote skin cell turnover. Antibiotics, either oral or topical, combat acne-causing bacteria and reduce inflammation, though concerns about antibiotic resistance persist. Salicylic acid and benzoyl peroxide are commonly prescribed medications for acne.
The Global Acne Medication Market is experiencing robust growth driven by several key factors. The rising prevalence of acne, unhealthy lifestyles, and the increase in the number of teenagers globally contribute significantly to market expansion. The growing awareness and emphasis on skincare routines have led more individuals to seek treatment for their acne, further propelling the demand for acne medications. The rise in the number of teenagers globally, characterized by hormonal changes during adolescence, directly correlates with the prevalence of acne, thereby driving the market growth. Unhealthy lifestyle choices, including poor dietary habits, lack of physical activity, inadequate sleep, and high levels of stress, contribute to the development and exacerbation of acne. Diets rich in processed foods, sugary snacks, and high-glycemic index foods have been associated with an increased risk of acne breakouts due to their potential to spike insulin levels and promote inflammation in the body. These factors collectively drive the demand for acne medication. However, concerns about antibiotic resistance and high costs of advanced treatments would hamper the market growth.
Key regions considered for the global Acne Medication market study include North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of the acne medication market in 2023 and is expected to maintain its dominance during the forecast period. This is attributed to a well-developed healthcare infrastructure, the strong presence of major key players, and a rise in awareness about skincare. However, Asia-Pacific is expected to register the highest CAGR during the forecast period owing to a surge in the teenage population and a rise in disposable income.